Cornerstone Advisors (Washington)’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $83K | Buy |
4,641
+234
| +5% | +$4.19K | 0.01% | 193 |
|
|
2020
Q2 | $79K | Buy |
4,407
+1,264
| +40% | +$22.7K | 0.01% | 195 |
|
|
2020
Q1 | $48K | Sell |
3,143
-364
| -10% | -$5.56K | 0.01% | 224 |
|
|
2019
Q4 | $69K | Buy |
3,507
+634
| +22% | +$12.5K | 0.01% | 198 |
|
|
2019
Q3 | $49K | Buy |
2,873
+1,252
| +77% | +$21.4K | 0.01% | 223 |
|
|
2019
Q2 | $29K | Sell |
1,621
-649
| -29% | -$11.6K | ﹤0.01% | 563 |
|
|
2019
Q1 | $46K | Buy |
2,270
+1,944
| +596% | +$39.4K | ﹤0.01% | 392 |
|
|
2018
Q4 | $5K | Buy |
+326
| New | +$5K | ﹤0.01% | 776 |
|